
Biography
Dr Jonathan Cohen is a consultant in Paediatric Immunology and Infectious Diseases at the Evelina Children’s Hospital where he has been Head of Service since 2023. He has a broad range of academic interests in paediatric infection from discovery and translational science through to clinical trials.
Jonathan has been PI for seven multi-centre clinical trials and two international observational studies, in addition to a number of leadership roles in international and multi-centre studies. He is currently leading a project investigating novel diagnostics for childhood respiratory infection.
He studied medicine at Cambridge and Oxford Universities before moving to London to train in paediatrics. An MRC Clinical Research Training Fellowship supported research into natural immunity against pneumococcal pneumonia leading to a PhD from the UCL Institute of Child Health. This research continued as an NIHR Academic Clinical Lecturer.
Jonathan previously worked as a consultant at UCLH from 2013 to 2021, where he held several clinical leadership roles, including Divisional Clinical Director, whilst continuing to pursue a range of research interests including migrant health and parasitic infections in children. He was founding co-Chair of the British Association for Paediatric Tuberculosis. He is currently Chair of the British Paediatric Allergy, Infection and Immunity Group and an Associate Editor of Archives of Disease in Childhood.
Research

Centre for Critical Illness Research
CCIR, a cross-faculty centre for academic excellence, focusses on critical illness.CCIR brings together interdisciplinary academics and clinicians to translate early scientific breakthroughs into effective prevention, diagnosis, and treatment strategies for critical illness and to enable healthy critical illness survivorship for children and adults.
Research

Centre for Critical Illness Research
CCIR, a cross-faculty centre for academic excellence, focusses on critical illness.CCIR brings together interdisciplinary academics and clinicians to translate early scientific breakthroughs into effective prevention, diagnosis, and treatment strategies for critical illness and to enable healthy critical illness survivorship for children and adults.